Skip to content
PharmaKnowl Logo
  • Home
  • About
  • Services
    • Regulatory Affairs Services
    • Pharmacovigilance Services
    • Quality Services
  • Blog
  • Resources
  • Patients
    • Report Side Effects
  • English
    • عربي
    • Deutsch
    • 简体中文
    • Français
    • Italiano
    • 日本語
    • 한국어
    • Español
    • Português
Contact Us

Post-Approval Activities

  1. Home
  2. Post-Approval Activities

Posts in Category: Post-Approval Activities

  • MDMA Update and Change of Information

  • Saudi Drug Information (SFDA SDI)

    Drug Information and Stock Reporting to SFDA (SDI)

  • SFDA recall procedure in Saudi Arabia

    Product Recall in Saudi Arabia

  • UDI services SFDA

    UDI Data Submission to SFDA for Medical Devices

  • SFDA-Variation types in the guidelines

    SFDA Variation Guidelines (Version 6.3)

Subscribe to our Newsletter

Receive the latest regulatory news and insights

This field is for validation purposes and should be left unchanged.
PharmaKnowl logo
  • Services
  • Quality Services
  • Regulatory Services
  • Pharmacovigilance Services
  • Blog
  • About
  • Contact Us
  • Report Side Effects

+966-11-277-7729

+966-11-240-4409

Support@pharmaknowl.com

© 2014 - 2025 • PharmaKnowl is a registered Trade Mark • Content Rights Reserved • Riyadh, Saudi Arabia

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
Page load link
  • Homepage
  • Our Services
    • Regulatory Affairs Services
    • Pharmacovigilance Services
    • Quality Services
  • About
  • Our Blog
  • Contact Us
  • English
    • عربي
    • Deutsch
    • 简体中文
    • Français
    • Italiano
    • 日本語
    • 한국어
    • Español
    • Português

Contact Our Business Support Team

Sunday to Thursday: 9:00 am – 5:00 pm

+966 11 277 7729

+966 11 240 4409

Go to Top